Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO AI and Digital Oncology 2025 | Integrating wearables in ongoing oncology studies and clinical workflows

Rosalind Picard, ScD, MIT Media Lab, Cambridge, MA, highlights the emerging use of wearable devices in oncology trials, particularly for monitoring sleep and stress changes. Stress and anxiety measures can help patients manage nausea and other side effects of treatment, and these devices can also enhance patient self-efficacy, allowing them to feel more in control and better equipped to manage their condition. This interview took place at the European Society for Medical Oncology (ESMO) 2025 Congress in Berlin, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Transcript

Yes, it’s new. They’re just starting to be used in oncology trials. They’re being used for, the ones I’ve seen so far, are being used for sleep and stress changes. In particular, the stress and anxiety measures are super interesting because a lot of patients experience nausea, And that’s one of the terrible side effects of the treatments. And to some extent, that’s the treatment...

Yes, it’s new. They’re just starting to be used in oncology trials. They’re being used for, the ones I’ve seen so far, are being used for sleep and stress changes. In particular, the stress and anxiety measures are super interesting because a lot of patients experience nausea, And that’s one of the terrible side effects of the treatments. And to some extent, that’s the treatment. But to some extent, and possibly in some cases, a much larger extent, it’s the anxiety of going in. They’re tossing their cookies before they even go in because of the, you know, the memories and helping them see the data that, you know, this really is an anxious response. And here’s something you can do to support it. Sometimes gives them a sense of greater control and management, which is really helpful. Right. When cancer is running through your body. right? Anything you can do to enhance a sense of patient self-efficacy that then results in them feeling better. And then when you feel better, you can manage everything else better. So when you go in for the treatment, you’re less likely to be very sick and needing somebody to talk to you for a long period of time. Or maybe you even need somebody to talk you into going back to the hospital or to the treatment center. So managing the patient stress and anxiety, I think, is an undervalued but great contribution to improving their health. There’s also improvements now in measuring lots of the other side effects. So the devices are being put in trials also for monitoring autonomic changes that relate to Cytokine Release Syndrome, which is another new area. So that’s very exciting.

This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.

Read more...